Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nyrie Soukiazian"'
Autor:
Bradley M. Turner, Mary Ann Gimenez‐Sanders, Armen Soukiazian, Andrea C. Breaux, Kristin Skinner, Michelle Shayne, Nyrie Soukiazian, Marilyn Ling, David G. Hicks
Publikováno v:
Cancer Medicine, Vol 8, Iss 9, Pp 4176-4188 (2019)
Abstract The skyrocketing cost of health‐care demands that we question when to use multigene assay testing in the planning of treatment for breast cancer patients. A previously published algorithmic model gave recommendations for which cases to sen
Externí odkaz:
https://doaj.org/article/b1be917011db4b41aedf1fbf7d9e2b92
Autor:
Bradley M. Turner, Nyrie Soukiazian, Hasan Khatib, David G. Hicks, Andrea Breaux, Mary Ann Sanders, Armen Soukiazian
Publikováno v:
Cancer Research. 80:P3-07
INTRODUCTION: The recent TAILORx results suggest that adjuvant endocrine therapy and chemoendocrine therapy had similar efficacy in women with hormone-positive, HER2-negative, node-negative invasive breast carcinomas with an Oncotype Dx® recurrence
Autor:
Kristin A. Skinner, David G. Hicks, Michelle Shayne, Mary C Jackson, Bradley M. Turner, Nyrie Soukiazian, Alissa Huston, Marilyn N. Ling, Ping Tang
Publikováno v:
Modern Pathology. 28:921-931
Oncotype DX (Genomic Health, Redwood City, CA, USA, current list price $4,350.00) is a multigene quantitative reverse transcription-polymerase chain reaction-based assay that estimates the risk of distant recurrence and predicts chemotherapy benefit